Growth Metrics

AIM ImmunoTech (AIM) EBIAT (2018 - 2023)

Historic EBIAT for ImmunoTech (AIM) over the last 8 years, with Q4 2023 value amounting to -$12.6 million.

  • ImmunoTech's EBIAT changed N/A to -$12.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$27.1 million, marking a year-over-year change of. This contributed to the annual value of -$17.3 million for FY2024, which is 4019.75% up from last year.
  • According to the latest figures from Q4 2023, ImmunoTech's EBIAT is -$12.6 million.
  • Over the past 5 years, ImmunoTech's EBIAT peaked at -$3.3 million during Q3 2020, and registered a low of -$12.6 million during Q4 2023.